Effects of Mobilized Balance Platform Exercises on Balance Parameters in Patients With Knee Osteoarthritis

Effects of Mobilized Balance Platform Exercises on Balance Parameters, Functional Status, and Pain in Patients With Knee Osteoarthritis: A Randomized Controlled Trial

This prospective single-blind randomized controlled study aims to investigate the effects of mobilized balance platform exercises on balance parameters, pain, functional status, fear of falling, and kinesiophobia in patients with knee osteoarthritis. A total of 36 patients diagnosed with knee osteoarthritis will be recruited from the outpatient clinic of Gaziler Physical Medicine and Rehabilitation Training and Research Hospital.

Participants will be randomly assigned to one of two groups. The control group will receive conventional physical therapy including transcutaneous electrical nerve stimulation (TENS) and a home exercise program consisting of knee strengthening, balance, range of motion, proprioceptive, and stretching exercises. The intervention group will receive the same conventional treatment in addition to mobilized balance platform exercises using the Huber 360 system.

Pain severity, functional status, balance parameters, fear of falling, and kinesiophobia will be evaluated before and after treatment by an assessor blinded to treatment allocation.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients aged between 45 and 65 years
  • Diagnosis of knee osteoarthritis classified as Kellgren-Lawrence grade 2 or 3
  • Willingness to participate voluntarily in the study

Exclusion Criteria:

  • Presence of orthopedic knee implants
  • Kellgren-Lawrence grade 1 or grade 4 knee osteoarthritis
  • Sensory impairment
  • Diagnosis of malignancy
  • Unhealed fractures
  • Circulatory disorders
  • Infection around the knee joint
  • Severe hearing loss or visual impairment
  • Cognitive impairment
  • Uncontrolled hypertension or diabetes mellitus
  • Vestibular disorders causing balance problems, such as vertigo
  • Use of walking assistive devices such as canes or walkers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Conventional Physical Therapy
Participants in this group will receive conventional physical therapy including transcutaneous electrical nerve stimulation (TENS) and a home exercise program. The home exercise program will include knee strengthening, balance, range of motion, proprioceptive, and stretching exercises, performed 3 days per week for 20 minutes.
Participants will receive conventional physical therapy including transcutaneous electrical nerve stimulation (TENS) and a home exercise program consisting of knee strengthening, balance, range of motion, proprioceptive, and stretching exercises performed 3 times per week for 20 minutes.
Experimental: Mobilized Balance Platform Exercise
Participants in this group will receive conventional physical therapy including TENS in addition to mobilized balance platform exercises using the Huber 360 system. The exercise protocol will include quadriceps and core strengthening, proprioceptive, balance, and neuromuscular exercises, performed 3 days per week for 20 minutes.
Participants will receive conventional physical therapy including transcutaneous electrical nerve stimulation (TENS) and a home exercise program consisting of knee strengthening, balance, range of motion, proprioceptive, and stretching exercises performed 3 times per week for 20 minutes.
Participants will perform mobilized balance platform exercises using the Huber 360 system. The exercise protocol will include quadriceps and core strengthening, proprioceptive training, balance exercises, and neuromuscular exercises specifically designed for patients with knee osteoarthritis. Sessions will be performed 3 times per week for 20 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Static and Dynamic Balance Parameters
Time Frame: Before treatment and immediately after completion of the 8-week treatment program
Balance performance will be assessed using the Huber 360 balance assessment system. Measurements will include static balance with eyes open and eyes closed, single-leg balance performance, and limits of stability.
Before treatment and immediately after completion of the 8-week treatment program

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Severity Assessed by Visual Analog Scale (VAS)
Time Frame: Before treatment and immediately after completion of the 8-week treatment program
Pain intensity will be assessed using a 10-cm Visual Analog Scale (VAS) for night pain, resting pain, and pain during movement. Higher scores indicate greater pain severity.
Before treatment and immediately after completion of the 8-week treatment program
Functional Status Assessed by WOMAC
Time Frame: Before treatment and immediately after completion of the 8-week treatment program
Functional status will be evaluated using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Higher scores indicate worse pain, stiffness, and functional limitation.
Before treatment and immediately after completion of the 8-week treatment program
Functional Mobility Assessed by Timed Up and Go Test
Time Frame: Before treatment and immediately after completion of the 8-week treatment program
Functional mobility and dynamic balance will be assessed using the Timed Up and Go Test. Shorter completion times indicate better functional mobility.
Before treatment and immediately after completion of the 8-week treatment program
Fear of Falling Assessed by the International Falls Efficacy Scale
Time Frame: Before treatment and immediately after completion of the 8-week treatment program
Fear of falling during activities of daily living will be evaluated using the International Falls Efficacy Scale. Higher scores indicate greater concern about falling.
Before treatment and immediately after completion of the 8-week treatment program
Kinesiophobia Assessed by Tampa Scale for Kinesiophobia
Time Frame: Before treatment and immediately after completion of the 8-week treatment program
Fear of movement and reinjury will be evaluated using the Tampa Scale for Kinesiophobia. Higher scores indicate greater fear of movement.
Before treatment and immediately after completion of the 8-week treatment program

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sefa Gümrük Aslan, gaziler physcial therapy and rehabilitation hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 4, 2026

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

October 30, 2026

Study Registration Dates

First Submitted

May 3, 2026

First Submitted That Met QC Criteria

May 3, 2026

First Posted (Actual)

May 8, 2026

Study Record Updates

Last Update Posted (Actual)

May 8, 2026

Last Update Submitted That Met QC Criteria

May 3, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • KOA-MBP-2026

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteearthritis

Clinical Trials on Conventional Physical Therapy

Subscribe